In last trading session, OnKure Therapeutics Inc (NASDAQ:OKUR) saw 0.31 million shares changing hands with its beta currently measuring 0.37. Company’s recent per share price level of $3.13 trading at -$0.76 or -19.54% at ring of the bell on the day assigns it a market valuation of $42.06M. That closing price of OKUR’s stock is at a discount of -538.98% from its 52-week high price of $20.00 and is indicating a discount of -22.04% from its 52-week low price of $3.82. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 46570.0 shares which gives us an average trading volume of 66.04K if we extend that period to 3-months.
OnKure Therapeutics Inc (NASDAQ:OKUR) trade information
Upright in the red during last session for losing -19.54%, in the last five days OKUR remained trading in the red while hitting it’s week-highest on Monday, 03/31/25 when the stock touched $3.13 price level, adding 32.98% to its value on the day. OnKure Therapeutics Inc’s shares saw a change of -63.60% in year-to-date performance and have moved -29.82% in past 5-day. OnKure Therapeutics Inc (NASDAQ:OKUR) showed a performance of -38.14% in past 30-days. Number of shares sold short was 1.1 million shares which calculate 30.24 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 35 to the stock, which implies a rise of 91.06% to its current value. Analysts have been projecting 35 as a low price target for the stock while placing it at a high target of 35. It follows that stock’s current price would drop -1018.21% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1018.21% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 4.41% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 66.23% while estimates for its earnings growth in next 5 years are of 39.48%.
OnKure Therapeutics Inc (NASDAQ:OKUR)’s Major holders
Insiders are in possession of 1.57% of company’s total shares while institution are holding 97.24 percent of that, with stock having share float percentage of 98.79%. Investors also watch the number of corporate investors in a company very closely, which is 97.24% institutions for OnKure Therapeutics Inc that are currently holding shares of the company.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 521.31 shares of worth $1.63 million or 4.09% of the total outstanding shares. The later fund manager was in possession of 168.13 shares on Dec 31, 2024 , making its stake of worth around $0.53 million in the company or a holder of 1.32% of company’s stock.
